Shine-On BioMedical Co.,Ltd. Share Price

Equities

6926

TW0006926009

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 23:00:00 18/06/2024 BST 5-day change 1st Jan Change
65.1 TWD -0.15% Intraday chart for Shine-On BioMedical Co.,Ltd. +0.46% -6.20%

Financials

Sales 2022 - Sales 2023 9.52 308.01 749.14 Capitalization 3.46B 112B 272B
Net income 2022 -19M -614M -1.49B Net income 2023 -37M -1.2B -2.91B EV / Sales 2022 -
Net cash position 2022 1.16B 37.66B 91.61B Net cash position 2023 1.14B 36.75B 89.39B EV / Sales 2023 243,556,699 x
P/E ratio 2022
-147 x
P/E ratio 2023
-92.5 x
Employees 19
Yield 2022 *
-
Yield 2023
-
Free-Float 81.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.15%
1 week+0.46%
Current month+0.31%
1 month+1.72%
3 months+1.72%
6 months+1.40%
Current year-6.20%
More quotes
1 week
65.00
Extreme 65
67.70
1 month
63.10
Extreme 63.1
67.70
Current year
61.10
Extreme 61.1
68.20
1 year
58.50
Extreme 58.5
80.00
3 years
45.00
Extreme 45
93.00
5 years
45.00
Extreme 45
93.00
10 years
45.00
Extreme 45
93.00
More quotes
Date Price Change Volume
19/06/24 65.1 -0.15% 17,100
18/06/24 65.2 -1.21% 10,100
17/06/24 66 0.00% 4,000
14/06/24 66 +1.69% 25,000
13/06/24 64.9 +0.15% 15,500

End-of-day quote Taipei Exchange, June 18, 2024

More quotes
Shine-On BioMedical Co Ltd is a Taiwan-based company mainly engaged in the research, development and manufacture of anti-cancer related new drug products. Antibody products include trispecific T cell engaging nanobody (SOA101), EphA10 trispecific antibody engaging immune cells (SOA201), iNb Intrabody nanoscale intracellular specific antibody drug (SOA102), iNb STAR TriTE T cell receptor Nano-scale trispecific antibody drug (SOA103). Nucleic acid drugs include exosome-carrying nucleic acid and chemotherapy drugs (SOB101).
More about the company